Bayer Healthcare Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc. must face jury trials on claims they didn’t adequately instruct doctors about the safe use of the blood thinner Xarelto (In re Xarelto (Rivaroxaban) Prods. Liab. Litig., 2017 BL 124938, E.D. La., MDL NO. 2592 SECTION L, 4/17/17)
Judgment for the drugmakers is inappropriate, Judge Eldon E. Fallon of the U.S. District Court for the Eastern District of Louisiana said April 17, shortly before the first Xarelto test trial.
Bayer and Janssen, a unit of Johnson & Johnson, face more than 15,000 Xarelto suits in federal court. More than 28 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.